108 related articles for article (PubMed ID: 12416557)
1. Degeneration of Pick bodies visualized by methenamine-silver staining and immunohistochemistry.
Odawara T; Iseki E; Furukawa Y; Suzuki K; Hino H; Kosaka K
Neuropathology; 2002 Sep; 22(3):180-5. PubMed ID: 12416557
[TBL] [Abstract][Full Text] [Related]
2. Clustering of Pick bodies in the dentate gyrus in Pick's disease.
Armstrong RA; Cairns NJ; Lantos PL
Neuropathology; 2000 Sep; 20(3):170-5. PubMed ID: 11132931
[TBL] [Abstract][Full Text] [Related]
3. Pick's disease: alpha- and beta-synuclein-immunoreactive Pick bodies in the dentate gyrus.
Mori F; Hayashi S; Yamagishi S; Yoshimoto M; Yagihashi S; Takahashi H; Wakabayashi K
Acta Neuropathol; 2002 Nov; 104(5):455-61. PubMed ID: 12410393
[TBL] [Abstract][Full Text] [Related]
4. Another phenotype of frontotemporal dementia and parkinsonism linked to chromosome-17 (FTDP-17) with a missense mutation of S305N closely resembling Pick's disease.
Kobayashi K; Kidani T; Ujike H; Hayashi M; Ishihara T; Miyazu K; Kuroda S; Koshino Y
J Neurol; 2003 Aug; 250(8):990-2. PubMed ID: 12928922
[No Abstract] [Full Text] [Related]
5. Perisomatic granules (non-plaque dystrophic dendrites) of hippocampal CA1 neurons in Alzheimer's disease and Pick's disease: a lesion distinct from granulovacuolar degeneration.
Probst A; Herzig MC; Mistl C; Ipsen S; Tolnay M
Acta Neuropathol; 2001 Dec; 102(6):636-44. PubMed ID: 11761725
[TBL] [Abstract][Full Text] [Related]
6. Expression of transcription factors c-Fos, c-Jun, CREB-1 and ATF-2, and caspase-3 in relation with abnormal tau deposits in Pick's disease.
Nieto-Bodelón M; Santpere G; Torrejón-Escribano B; Puig B; Ferrer I
Acta Neuropathol; 2006 Apr; 111(4):341-50. PubMed ID: 16496165
[TBL] [Abstract][Full Text] [Related]
7. Extracellular or ghost Pick bodies and their lack of tau immunoreactivity: a histological, immunohistochemical and electron microscopic study.
Izumiyama Y; Ikeda K; Oyanagi S
Acta Neuropathol; 1994; 87(3):277-83. PubMed ID: 8009959
[TBL] [Abstract][Full Text] [Related]
8. Pick's disease: hyperphosphorylated tau protein segregates to the somatoaxonal compartment.
Probst A; Tolnay M; Langui D; Goedert M; Spillantini MG
Acta Neuropathol; 1996 Dec; 92(6):588-96. PubMed ID: 8960316
[TBL] [Abstract][Full Text] [Related]
9. Glycogen synthase kinase-3 is associated with neuronal and glial hyperphosphorylated tau deposits in Alzheimer's disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration.
Ferrer I; Barrachina M; Puig B
Acta Neuropathol; 2002 Dec; 104(6):583-91. PubMed ID: 12410379
[TBL] [Abstract][Full Text] [Related]
10. Phosphorylated mitogen-activated protein kinase (MAPK/ERK-P), protein kinase of 38 kDa (p38-P), stress-activated protein kinase (SAPK/JNK-P), and calcium/calmodulin-dependent kinase II (CaM kinase II) are differentially expressed in tau deposits in neurons and glial cells in tauopathies.
Ferrer I; Blanco R; Carmona M; Puig B
J Neural Transm (Vienna); 2001; 108(12):1397-415. PubMed ID: 11810404
[TBL] [Abstract][Full Text] [Related]
11. Pick-body-like inclusions in corticobasal degeneration differ from Pick bodies in Pick's disease.
Ikeda K; Akiyama H; Arai T; Tsuchiya K
Acta Neuropathol; 2002 Feb; 103(2):115-8. PubMed ID: 11810176
[TBL] [Abstract][Full Text] [Related]
12. Neuronal and glial tau pathology in early frontotemporal lobar degeneration-tau, Pick's disease subtype.
Mimuro M; Yoshida M; Miyao S; Harada T; Ishiguro K; Hashizume Y
J Neurol Sci; 2010 Mar; 290(1-2):177-82. PubMed ID: 20022024
[TBL] [Abstract][Full Text] [Related]
13. Neuropathological discrepancy between Japanese Pick's disease without Pick bodies and frontal lobe degeneration type of frontotemporal dementia proposed by Lund and Manchester Group.
Ikeda K
Neuropathology; 2000 Mar; 20(1):76-82. PubMed ID: 10935442
[TBL] [Abstract][Full Text] [Related]
14. KP1 expression of ghost Pick bodies, amyloid P-positive astrocytes and selective nigral degeneration in early onset Picks disease.
Kobayashi K; Hayashi M; Fukutani Y; Miyazu K; Shiozawa M; Muramori F; Aoki T; Koshino Y
Clin Neuropathol; 1999; 18(5):240-9. PubMed ID: 10505433
[TBL] [Abstract][Full Text] [Related]
15. Severity of gliosis in Pick's disease and frontotemporal lobar degeneration: tau-positive glia differentiate these disorders.
Schofield E; Kersaitis C; Shepherd CE; Kril JJ; Halliday GM
Brain; 2003 Apr; 126(Pt 4):827-40. PubMed ID: 12615642
[TBL] [Abstract][Full Text] [Related]
16. Heparan sulfate proteoglycans recognize ghost Pick bodies.
Odawara T; Iseki E; Li F; Kosaka K; Ikeda K
Neurosci Lett; 1998 Feb; 242(2):120-2. PubMed ID: 9533409
[TBL] [Abstract][Full Text] [Related]
17. Structural analysis of Pick's disease-derived and in vitro-assembled tau filaments.
King ME; Ghoshal N; Wall JS; Binder LI; Ksiezak-Reding H
Am J Pathol; 2001 Apr; 158(4):1481-90. PubMed ID: 11290566
[TBL] [Abstract][Full Text] [Related]
18. A double-labeling immunohistochemical study of tau exon 10 in Alzheimer's disease, progressive supranuclear palsy and Pick's disease.
Ishizawa K; Ksiezak-Reding H; Davies P; Delacourte A; Tiseo P; Yen SH; Dickson DW
Acta Neuropathol; 2000 Sep; 100(3):235-44. PubMed ID: 10965792
[TBL] [Abstract][Full Text] [Related]
19. Three-repeat Tau 69 is a major tau isoform in laser-microdissected Pick bodies.
Ohkubo T; Sakasegawa Y; Toda H; Kishida H; Arima K; Yamada M; Takahashi H; Mizusawa H; Hachiya NS; Kaneko K
Amyloid; 2006 Mar; 13(1):1-5. PubMed ID: 16690493
[TBL] [Abstract][Full Text] [Related]
20. Pick body disease and Pick syndrome.
Uchihara T; Ikeda K; Tsuchiya K
Neuropathology; 2003 Dec; 23(4):318-26. PubMed ID: 14719549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
